International Clinical Trial: A single-center, single-arm, open-label efficacy exploration and observation study on the treatment of occipital neuralgia with Kligabalin

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127084) titled 'A single-center, single-arm, open-label efficacy exploration and observation study on the treatment of occipital neuralgia with Kligabalin' on June 24.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Affiliated Hospital of Xi'an Jiaotong University

Condition: occipital neuralgia

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-07-01

Target Sample Size: Crisugabalin Besilate Capsules Treatment Group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=317157

Published by HT Digital Content...